ImageneBio, Inc. Common Stock
$4.92
-$0.08 (-1.60%)
$4.76Day Range$5.19
Key Statistics
Market Cap
$55.85M
Shares Outstanding
11.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 28, 2025
Round Lot
100
Locale
US
Trading Data
Day Open
$4.99
Day High
$5.19
Day Low
$4.76
Volume
14.2K
VWAP
$5.01
Prev Close
$5.00
Transactions
--
Acc. Volume
--
About ImageneBio, Inc. Common Stock
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 283618 employees12526 HIGH BLUFF DRIVE, SAN DIEGO, CA, 92130857-343-8292IPO Jul 28, 2025US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001835579
- Composite FIGI
- BBG00XZY4TG9
- Share Class FIGI
- BBG00XZY4TH8
- Ticker Root
- IMA
- SIC Code
- 2836
About ImageneBio, Inc. Common Stock (IMA) Stock
ImageneBio, Inc. Common Stock (IMA) closed the 2026-09-15 session at $4.92, down 1.60% versus the previous close (-0.08). The stock opened at $4.99 and traded between $4.76 and $5.19 during that session. Session trading volume was 14K shares. The volume-weighted average price (VWAP) is $5.01.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
ImageneBio, Inc. Common Stock has a market capitalization of $55.8 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. IMA is listed on the XNAS exchange. The company employs approximately 18 people. ImageneBio, Inc. Common Stock is headquartered in SAN DIEGO, CA. The recorded listing date is 2025-07-28.
On this page you can find market IMA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.